CVSA vs GHC
Covista Inc. and Graham Holdings Co., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | CVSA | GHC |
|---|---|---|
| Revenue | $2.0B | $4.9B |
| Net income | $251.6M | $292.3M |
| Gross margin | 57.3% | · |
| Net margin | 12.9% | 6.2% |
| Return on equity | 17.5% | 6.5% |
| Diluted EPS | $7.04 | $66.47 |
| Dividend / share | · | $7.20 |
| Payout ratio | · | · |
| Free cash flow | $392.7M | $275.3M |
| Equity | $1.4B | $4.8B |
| Net debt / equity | 0.18× | 0.13× |
| Current ratio | 1.09× | 1.75× |
| Revenue CAGR 5y | 16.8% | 11.2% |
| Profit CAGR 5y | 29.1% | −0.5% |
GHC bills 2.5× the revenue of CVSA, and CVSA keeps more of each dollar of revenue as profit (12.9% against 6.2%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | CVSA | GHC |
|---|---|---|
| FY2025 | $2.0B | $4.9B |
| FY2024 | $1.8B | $4.8B |
| FY2023 | $1.6B | $4.4B |
| FY2022 | $1.5B | $3.9B |
| FY2021 | $1.4B | $3.2B |
| FY2020 | $899.2M | $2.9B |
| FY2019 | $866.4M | $2.9B |
| FY2018 | $1.0B | $2.7B |
| FY2017 | $960.3M | $2.6B |
| FY2016 | $1.2B | $2.5B |
Bottom line
| Fiscal year | CVSA | GHC |
|---|---|---|
| FY2025 | $251.6M | $292.3M |
| FY2024 | $237.1M | $724.6M |
| FY2023 | $136.8M | $205.3M |
| FY2022 | $93.4M | $67.1M |
| FY2021 | $311.0M | $352.1M |
| FY2020 | $70.0M | $300.4M |
| FY2019 | $-85.3M | $327.9M |
| FY2018 | $95.2M | $271.2M |
| FY2017 | $33.8M | $302.0M |
| FY2016 | $122.3M | $168.6M |
18 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −$2,957,478,000 | GHC |
| FY2024 | −$3,002,614,000 | GHC |
| FY2023 | −$2,830,225,000 | GHC |
| FY2022 | −$2,473,667,000 | GHC |
| FY2021 | −$1,804,132,000 | GHC |
| FY2020 | −$1,989,873,000 | GHC |
| FY2019 | −$2,065,672,000 | GHC |
| FY2018 | −$1,682,123,000 | GHC |
| FY2017 | −$1,631,569,000 | GHC |
| FY2016 | −$1,273,981,000 | GHC |
| FY2015 | −$1,506,039,000 | GHC |
| FY2014 | −$827,089,000 | GHC |
| FY2013 | −$677,231,000 | GHC |
| FY2012 | −$1,408,211,000 | GHC |
| FY2011 | −$3,175,494,000 | GHC |
| FY2010 | −$4,317,374,000 | GHC |
| FY2009 | −$2,410,859,000 | GHC |
| FY2008 | −$2,750,262,000 | GHC |
GHC has reported the higher revenue in every one of these 18 fiscal years. The gap has widened since the earliest year compared.
18 of 18 comparable fiscal years — a year missing data on either side is not counted.
18 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +6.7 pp | CVSA |
| FY2024 | −2.0 pp | GHC |
| FY2023 | +3.8 pp | CVSA |
| FY2022 | +4.6 pp | CVSA |
| FY2021 | +11.4 pp | CVSA |
| FY2020 | −2.6 pp | GHC |
| FY2019 | −21.1 pp | GHC |
| FY2018 | −0.6 pp | GHC |
| FY2017 | −8.1 pp | GHC |
| FY2016 | +3.4 pp | CVSA |
| FY2015 | +3.6 pp | CVSA |
| FY2014 | −39.9 pp | GHC |
| FY2013 | −2.1 pp | GHC |
| FY2012 | +1.6 pp | CVSA |
| FY2011 | +37.3 pp | CVSA |
| FY2010 | +116.9 pp | CVSA |
| FY2009 | +12.5 pp | CVSA |
| FY2008 | +9.8 pp | CVSA |
The higher net margin has changed hands between CVSA and GHC over this period.
18 of 18 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
CVSA's net margin has been more volatile than GHC's over the 18 comparable fiscal years — 27.7 percentage points of standard deviation against 10.4.
18 of 18 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between CVSA and GHC over these 18 fiscal years — CVSA led in 11 and GHC in 7.
18 of 18 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
GHC's return on equity has been more volatile than CVSA's over the 17 comparable fiscal years — 9.0 percentage points of standard deviation against 8.6.
17 of 18 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between CVSA and GHC over these 17 fiscal years — CVSA led in 11 and GHC in 6.
17 of 18 comparable fiscal years — a year missing data on either side is not counted.